These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12466030)

  • 41. A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder.
    Urbano M; Okwara L; Manser P; Hartmann K; Herndon A; Deutsch SI
    Clin Neuropharmacol; 2014; 37(3):69-72. PubMed ID: 24824660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
    Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. d-cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study.
    Cascella NG; Macciardi F; Cavallini C; Smeraldi E
    J Neural Transm Gen Sect; 1994; 95(2):105-11. PubMed ID: 7865165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects.
    van Berckel BN; Lipsch C; Timp S; Gispen-de Wied C; Wynne H; van Ree JM; Kahn RS
    Neuropsychopharmacology; 1997 May; 16(5):317-24. PubMed ID: 9109102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
    Olden M; Wyka K; Cukor J; Peskin M; Altemus M; Lee FS; Finkelstein-Fox L; Rabinowitz T; Difede J
    J Nerv Ment Dis; 2017 Feb; 205(2):154-160. PubMed ID: 27441461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: A randomized, double blind, clinical trial.
    Attari A; Rajabi F; Maracy MR
    J Res Med Sci; 2014 Jul; 19(7):592-8. PubMed ID: 25364356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.
    Davis LL; Ward C; Rasmusson A; Newell JM; Frazier E; Southwick SM
    Psychopharmacol Bull; 2008; 41(1):8-18. PubMed ID: 18362867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia.
    Rosse RB; Fay-McCarthy M; Kendrick K; Davis RE; Deutsch SI
    Clin Neuropharmacol; 1996 Oct; 19(5):444-50. PubMed ID: 8889288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of cycloserine in the treatment of Alzheimer's disease.
    Fakouhi TD; Jhee SS; Sramek JJ; Benes C; Schwartz P; Hantsburger G; Herting R; Swabb EA; Cutler NR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):226-30. PubMed ID: 8561836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
    Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
    Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
    Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
    Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilot trial of memantine in the treatment of posttraumatic stress disorder.
    Battista MA; Hierholzer R; Khouzam HR; Barlow A; O'Toole S
    Psychiatry; 2007; 70(2):167-74. PubMed ID: 17661541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study.
    Bremner JD; Mletzko T; Welter S; Quinn S; Williams C; Brummer M; Siddiq S; Reed L; Heim CM; Nemeroff CB
    J Psychopharmacol; 2005 Mar; 19(2):159-65. PubMed ID: 15728437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.
    Heresco-Levy U; Gelfin G; Bloch B; Levin R; Edelman S; Javitt DC; Kremer I
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):501-6. PubMed ID: 23174090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders.
    Urbano M; Okwara L; Manser P; Hartmann K; Deutsch SI
    J Neuropsychiatry Clin Neurosci; 2015; 27(2):133-8. PubMed ID: 25923852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.
    Bahk WM; Pae CU; Tsoh J; Chae JH; Jun TY; Chul-Lee ; Kim KS
    Hum Psychopharmacol; 2002 Oct; 17(7):341-4. PubMed ID: 12415552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
    Weiser M; Heresco-Levy U; Davidson M; Javitt DC; Werbeloff N; Gershon AA; Abramovich Y; Amital D; Doron A; Konas S; Levkovitz Y; Liba D; Teitelbaum A; Mashiach M; Zimmerman Y
    J Clin Psychiatry; 2012 Jun; 73(6):e728-34. PubMed ID: 22795211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.